References
- Keating M.J. Chemotherapy of chronic lymphocytic leukemia. Chronic Lymphocytic Leukemia: Scientific Advances and Clinical Developments, B. Cheson. Marcel Dekker, New York, NY 1993; 297–336
- Grever M.R., Kopecky K.J., Coltman C.A., Files J.C., Greenberg B.R., Hutton J.J., Von Talky R., Hoff D.D., Balcerzak S.P. Fludarabine monophosphate: A potentially useful agent in chronic lymphocytic leukemia. Nouvelle Revue Francaise Hematologie 1988; 30: 457–459
- Keating M.J., O'Brien S., Kantarjian H., Plunkett W., Estey E., Koller C., Beran M., Freireich E.J. Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood 1993; 81: 2878–2884
- Johnson S.A., Hiddeman W., Coiffier B., Fenaux P., Smith A., Loffler H., Bjorkholm M., Kimby E., Dengler R., Oscier D., Catovsky D., Thiel E., Wyld P., Binet J.L. A randomised comparison between fludarabine and cyclophosphamide, adriamycin and prednisolone in the treatment of chronic lymphocytic leukemia(CLL). Br. J. Haematol. 1994; 87: 169, Suppl 1 abstract 661
- Robertson L.E., Huh Y.O., Butler J.J., Pugh W.C., Hirsch-Ginsberg C., Stass S., Kantarjian H., Keating M.J. Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: Clinical pathologic, immunophenotypic, and molecular analysis. Blood 1992; 80: 29–36
- Khouri I.F., Keating M.J., Vriesendorp H.M., Reading C.L., Przepiorka D., Huh Y.O., Anderson B.S., van Besien K.W., Mehra R.C., Giralt S.A., Ippoliti C., Marshall M., Thomas M.W., O'Brien S., Robertson L.E., Deisseroth A.B., Champlin R.E. Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: Preliminary results. J. Clin. Oncol. 1994; 12: 748–758
- Michallet M. Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: 55 cases. Report of the European Bone Marrow Transplantation and International Bone Marrow Transplantation Registry. Proceedings of the Fifth International Conference on Malignant Lymphoma. Lugano, Switzerland June 9–12, 1993; 103, abstract P132
- Rabinowe S.N., Soiffer R.J., Gribben J.G., Daley H., Freedman A.S., Daley J., Pesek K., Neuberg D., Pinkus G., Leavitt P.R., Spector N.A., Grossbard M.L., Anderson K., Robertson M.J., Mauch P., Chayt-Marcus K., Ritz J., Nadler L.M. Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1366–1376
- Finch S.C., Linet M.S. Chronic leukemias. Bailliere's Clin. Hematol. 1992; 5: 27–56
- Cheson B.D., Bennett J.M., Rai K.R., Grever M.R., Kay N.E., Schiffer C.A., Oken M.M., Keating M.J., Boldt D.H., Kempin S.J., Foon K.A. Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the National Cancer Institute-sponsored Working Groups. Am. J. Hematol. 1988; 29: 152–163
- Kemena A., O'Brien S., Kantarjian H., Robertson L., Koller C., Beran M., Estey E., Plunkett W., Lerner S., Keating M.J. Phase II clinical trial of fludarabine in chronic lymphocytic leukemia on a weekly low-dose schedule. Leukemia and Lymphoma 1993; 10: 187–193
- O'Brien S., Kantarjian H., Beran M., Smith T., Koller C., Estey E., Robertson L.E., Lerner S., Keating M. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multi-variate analysis-derived prognostic model for response to treatment. Blood 1993; 82: 1695–1700
- Robertson L.E., Kantarjian H., O'Brien S., Yang L.Y., Gandhi V., Lerner S., Plunkett W., Keating M.J. Cisplatin, fludarabine and ara-C (PFA): A regimen for advanced fludarabine refractory chronic lymphocytic leukemia (CLL). Proc. Amer. Soc. Clin. Oncol. 1993; 12: 308, abstract 1014
- Michallet M., Archimbaud E., Juliusson G., Bastion Y., Sutton L., Cahn J.Y., Neidhard E.M., Fiere D., Coiffier B., Gahrton G., Binet J.L. Autologous transplants in chronic lymphocytic leukemia: Report of 11 cases. Br. J. Haematol. 1994; 87: 172, Suppl 1 abstract 671